Treatment Options and the Path to Seizure Freedom

Treating Sleep-related hypermotor epilepsy (SHE) is a journey that often begins with medication, but for some, it may lead toward surgical or device-based options. The goal of any treatment is not just to stop the nocturnal movements, but to restore restful sleep and improve your quality of life ^[1][2].

First-Line Medications

A commonly considered “first-line” treatment for SHE is carbamazepine. Many patients with SHE respond well to this medication, often seeing a significant reduction in seizures ^[1][3]. However, it carries important safety considerations: it can cause dizziness, double vision, and rare but severe skin rashes. It requires monitoring of blood counts and liver function, and it strongly interacts with other drugs, including hormonal birth control.

Another closely related drug, oxcarbazepine, is also frequently used and has shown effectiveness, including in families with genetic forms of SHE ^[2][3]. It carries a specific risk of hyponatremia (low blood sodium) and requires periodic blood tests.

If the first medication is not enough, causes too many side effects, or interacts with other conditions, your doctor might suggest “add-on” or second-line medications. These can include:

• Topiramate: Can be effective, but carries risks of cognitive side effects (“brain fog”) and kidney stones ^[1].
• Lacosamide: An option that requires consideration of cardiac conduction (how the heart’s electrical system works) ^[4].
• Perampanel: A newer option that has shown promise, but carries a “black box” warning for potentially serious mood or behavioral changes, such as aggression ^[5].
• Acetazolamide: A carbonic-anhydrase inhibitor sometimes added based on limited evidence in SHE ^[1].

Safety Warning: Never stop taking your antiseizure medication abruptly, as this can trigger prolonged or severe seizures. Always discuss medication changes and pregnancy/contraception planning with your prescriber.

When Medications Aren’t Enough

While many people find relief with medication, SHE can be difficult to manage. Approximately 30% of patients are considered drug-resistant ^[1][2]. Drug resistance is formally defined as the failure of two appropriately chosen, tolerated, adequately dosed and adequately timed medication trials taken as prescribed, after confirming that the events are epileptic.

If you meet this definition—or if the diagnosis is uncertain, or side effects are unmanageable—it is highly recommended to seek an evaluation at a comprehensive epilepsy center. These specialized centers have experts who can look beyond standard medications ^[1][6].

The Path to Surgery and Alternatives

For carefully selected patients with drug-resistant SHE, surgery may provide seizure freedom. However, surgery has material risks and is not an option for everyone.

The Evaluation Process

Before surgery, a team of specialists must find the exact “seizure-onset zone”—the tiny patch of brain tissue where the electrical storm begins. This evaluation includes:

1. Epilepsy-Protocol MRI: A high-resolution scan designed to find subtle abnormalities like focal cortical dysplasia (small areas of misformed brain cells) ^[2][7].
2. SEEG (Stereo-electroencephalography): Because SHE seizures often start deep in the brain where surface sensors can’t reach, doctors may use SEEG. This is an invasive diagnostic procedure using stereotactically implanted depth electrodes placed directly into the brain to map where the seizures start ^[8][9]. SEEG carries risks such as bleeding and infection.
3. Neuropsychological Testing: Assessing memory, language, and thinking skills to ensure surgery won’t harm eloquent cortex (areas controlling vital functions) ^[2].

Surgical Outcomes and Alternatives

If a clear “focus” is found and can be safely removed without affecting vital functions, resection can be highly effective. In selected surgical cohorts, a substantial proportion become seizure-free, and successful surgery often repairs the “sleep fragmentation” that causes daytime fatigue ^[1][2]. However, presurgical testing may fail to localize a single target, or may reveal a distributed network that cannot be resected.

When resection is not appropriate, epilepsy centers offer alternative treatments, such as continued medical management, dietary therapies, or neuromodulation (devices that send electrical pulses to the brain to disrupt seizures).